DPP-4 inhibitor BI-1356, Purity ≥98%

Cat. No.: X24-07-ZQ710

DPP-4 inhibitor BI-1356, Purity ≥98%

Synonym: 668270-12-0; DPP-4 inhibitor; BI-1356; Tradjenta; Trajenta

  • MDL: MFCD14635356
  • CAS Number: 668270-12-0
  • Compound CID: 10096344
Product Size
100 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
BI-1356, soluble in DMSO and ethanol and insoluble in water, prolongs the action of incretin hormones, thereby improving blood glucose control. It targets DPP-4.
Molecular Weight
472.5
Molecular Formula
C25H28N8O2
Targets
DPP-4: 1 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 16 mg/mL (33.85 mM); Water: Insoluble; Ethanol: 1 mg/mL (2.11 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
BI-1356 is used in studies targeting DPP-4 inhibition, contributing to diabetes research and treatment development.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0